Skip to main content
. 2022 Jan 18;20(2):83. doi: 10.3390/md20020083

Table 4.

Inhibitory effects of ligiamycins on the proliferation of human cancer cell lines.

IC50 (μM) SNU638 SK-HEP-1 A549 HCT116 MDA-MB-23
Ligiamycin A (1) >50 >50 42.0 >50 >50
Ligiamycin B (2) 46.2 34.6 25.9 20.1 23.7
Etoposide 2.17 0.24 0.35 0.66 2.64